| Item | Cat. No. | Type | Clone No |
| Anti-C5;ALB mAbs [Gefurulimab Biosimilar] (MABL-4750) | MABL-4750 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-SIGLEC3/CD33/p67 mAbs [Gemtuzumab Biosimilar] (MABL-4751) | MABL-4751 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Geptanolimab Biosimilar] (MABL-4752) | MABL-4752 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL1B mAbs [Gevokizumab Biosimilar] (MABL-4753) | MABL-4753 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-CALCA and CALCB mAbs [Fremanezumab Biosimilar] (MABL-4725) | MABL-4725 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-Fel d 1 mAbs [Freneslerbart Biosimilar] (MABL-4726) | MABL-4726 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TGFB mAbs [Fresolimumab Biosimilar] (MABL-4727) | MABL-4727 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD40LG/CD154 mAbs [Frexalimab Biosimilar] (MABL-4728) | MABL-4728 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PCSK9 mAbs [Frovocimab Biosimilar] (MABL-4729) | MABL-4729 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-NGFB mAbs [Frunevetmab Biosimilar] (MABL-4730) | MABL-4730 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB mAbs [Fulranumab Biosimilar] (MABL-4731) | MABL-4731 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-CTLA4/CD152 mAbs [Futermestotug Biosimilar] (MABL-4732) | MABL-4732 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Futuximab Biosimilar] (MABL-4733) | MABL-4733 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F4+ ETEC (Veterinary Application) mAbs [Gacovetug Biosimilar] (MABL-4734) | MABL-4734 | ELISA, FACS, Functional assay, in vivo binding | A1, na |
| Anti-CALCA and CALCB mAbs [Galcanezumab Biosimilar] (MABL-4735) | MABL-4735 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-HTRA1 mAbs [Galegenimab Biosimilar] (MABL-4736) | MABL-4736 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-B7/CD80/CD28LG mAbs [Galiximab Biosimilar] (MABL-4737) | MABL-4737 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-IL17A and IL17F;ALB mAbs [Galvokimig1 Biosimilar] (MABL-4738) | MABL-4738 | ELISA, FACS, Functional assay, in vivo binding | G1;na, Kappa;Kappa |
| Anti-IL13 mAbs [Galvokimig2 Biosimilar] (MABL-4739) | MABL-4739 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-ERBB2/CD340/HER2 mAbs [Gancotamab Biosimilar] (MABL-4740) | MABL-4740 | ELISA, FACS, Functional assay, in vivo binding | na, Lambda |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
